• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 XPI - AFP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 XPI - AFP Back to Search Results
Model Number IMMULITE 2000 XPI - AFP
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/16/2019
Event Type  malfunction  
Manufacturer Narrative
The customer contacted siemens customer care center.Siemens headquarters support center (hsc) is reviewing the data provided by the customer.Calibrations and quality control (qc) were all checked and are within expected limits.The cause for the discordant falsely depressed afp sample results is unknown.Siemens is investigating the issue.
 
Event Description
Two discordant, falsely depressed alpha-fetoprotein (afp) results were obtained using immulite 2000 xpi.The initial result was reported to the physician(s).A repeat result was obtained on immulite 2000 xpi and was considered discordant.Additional repeated results were obtained using siemens' advia centaur xp.The repeat results from advia centaur xp were considered correct and reported to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the discordant, falsely depressed afp results.
 
Manufacturer Narrative
Siemens filed initial mdr 2432235-2019-00408 on 15-nov-2019.Additional information (19-nov-2019): siemens headquarters support center (hsc) reviewed the information provided by the customer.Hsc found that the patient was diagnosed with chronic hepatitis.The immulite 2000 -afp instructions for use (ifu) indicates that patients with chronic active hepatitis may present elevated concentrations of serum afp.The assay is not intended to be used with patients who do not have nonseminomatous testicular cancer or are not being screened for maternal purposes.As the patient is neither a maternal screening patient nor a patient with nonseminomatous testicular cancer the assay is not being used in alignment with the intended use.There is no product non-conformance identified and the results were discussed with the customer and no further support was required.The instrument is performing within specification.No further evaluation of the device is required.Section(s) h6 and h10 were updated to reflect the additional information provided on 19-nov-2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMMULITE 2000 XPI - AFP
Type of Device
IMMULITE 2000 XPI - AFP
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
glyn rhonwy
llanberis, LL55 4EL
EI  LL55 4EL
MDR Report Key9329763
MDR Text Key219294042
Report Number2432235-2019-00408
Device Sequence Number1
Product Code LOK
UDI-Device Identifier00630414961033
UDI-Public00630414961033
Combination Product (y/n)N
PMA/PMN Number
P010007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 12/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/15/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2020
Device Model NumberIMMULITE 2000 XPI - AFP
Device Catalogue Number10381187
Device Lot Number502
Was Device Available for Evaluation? No
Date Manufacturer Received11/19/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-